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Introduction
The renin-angiotensin system (RAS) is a multiregulated proteolytic cascade that produces two potent pressor and aldosteronogenic peptides; an octapeptide, angiotensin II, and a heptapeptide, angiotensin III.1) Although the exact role that the RAS plays in the maintenance of normal blood pressure is unclear, it has been reported that pharmacological interruption of the RAS can lower blood pressure in a majority of hypertensive patients.2) Specificially, inhibitors of angiotensin I converting enzyme (ACE) have been receiving much attention as antihypertensive drugs.
Since Ondetti et al. developed captopril in 1977,3) many ACE inhibitors4) including MK-421 have been synthesized. Most of these agents, as well as the naturally occurring ACE inhibitors, have proline, a cyclic amino acid, as the COOH-terminal residue. As part of a program on the development of novel ACE inhibitors, we synthesized N-mercaptoalkanoyl derivatives of sulfur-containing amino acids, as shown in Fig. 1 , and tested them for ability to inhibit ACE.
Chemistry
The compounds listed in Table I were prepared by standard synthetic techniques (Chart 
Biological Results and Discussion
We evaluated the inhibitory effects of N-mercaptoalkanoyl derivatives of sulfurcontaining amino acids on ACE activity in vitro. The IC50 values of test compounds on ACE are summarized in Table I .
In Fig. 1 , the sulfur-containing amino acid moiety of the compounds with n = 1 is an Lcysteine derivative. The amino acid moiety in the case of the compounds with n=2 is DLmethionine or DL-ethionine (for 13b, L-configuration).
The ACE-inhibitory activity of compounds with S-methylcysteine (13a) and Sethylcysteine (13c) as the sulfur-containing amino acid moiety was more potent than that of compounds with methionine (13b) and ethionine (13d). On the other hand, the inhibitory action of 12b (m = 1) was more potent than that of 10b (m=0). These results suggest that the structure-activity correlation concerning the length of the carbon chain is as follows:
Replacement of the methyl group (12h) with benzyl (13h) at the R'-position led to enhancement of the inhibitory potency. In addition, based on the inhibitory activities of compounds 11b, 12b and 13b on ACE activity, the structure-activity correlation for substitution at the R'-position was concluded to be as follows: benzyl >CH3 >H. In compounds having benzyl at the IV-position, the effectiveness of R2 substituents on inhibitory activity was in the order CH, (13a), C2H5 (13c) > benzyl (13h) > C3H, (13e), CH, 
